pneumococcal vaccine

August 31, 2020

Vaccine narrows racial disparities in pneumococcal disease

In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease.

By Paul Govern
November 6, 2014

Pneumonia vaccine reducing pediatric admissions: report

In Tennessee, the introduction in 2010 of a new pneumococcal vaccine for infants and young children coincides with a 27 percent decline in pneumonia hospital admissions across the state among children under age 2.

By Paul Govern